Kevin Robert Lind - Feb 9, 2023 Form 4 Insider Report for Longboard Pharmaceuticals, Inc. (LBPH)

Role
CEO, Director
Signature
/s/ Brandi L. Roberts, Attorney-In-Fact
Stock symbol
LBPH
Transactions as of
Feb 9, 2023
Transactions value $
$0
Form type
4
Date filed
2/10/2023, 03:27 PM
Previous filing
Feb 11, 2022
Next filing
Feb 9, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LBPH Stock Option (Right to Buy) Award $0 +326K $0.00 326K Feb 9, 2023 Voting common stock 326K $4.35 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the stock option vest and become exercisable in 48 equal monthly installments commencing March 9, 2023.